Skip to main content
Transparency
Twitter
YouTube
Linkedin
cat
esp
eng
ABOUT US
RESEARCH
COVID-19
INNOVATION AND TRANSFER
LEARNING
LIVING LAB HEALTH
NEWS
COLLABORATE
Cerca
who are you?
Who are you?
I'm an
Investigator
I'm
Community
I'm an
Educator
or Student
I'm a
Collaborator
I'm a
Journalist
IrsiCaixa’s scientific activity search engine
Search by
Filter by strategic line
All lines
Immunopathogenesis
Microbiome
Other diseases
Prevention, eradication and functional cure
New treatments and resistance to antiretrovirals
Filter by research group
All the groups
Retrovirology and Clinical Studies (GREC)
Cell Virology and Immunology (VIC)
Microbial Genomics
Virus-Host Interactions (ViHIT)
Host Genetics and Cellular Immunity
HIV and HCV Genetic and Phenotypic Variability
Tissue Virology (VITI)
Viral Immune Evasion and Vaccines (VIRIEVAC)
Neoantigens and Therapeutic Vaccines for Cancer (NeoVaCan)
Pathogen immunity, signaling and therapeutic applications (PISTA)
Translational Research in Immunology and Aging (TRIA)
From Date
Date
To Date
Date
Search
Filter by category
Strategic lines
Research groups
Researchers
Projects
Publications
Clinical research
Events
Publication
Inferior clinical outcome of the CD4+ cell count-guided antiretroviral treatment interruption strategy in the SMART study: role of CD4+ Cell counts and HIV RNA levels during follow-up.
Publication
Intrahepatic mRNA expression in hepatitis C virus and HIV/hepatitis C virus co-infection: infiltrating cells, cytokines, and influence of HAART.
Publication
Intrahepatic mRNA expression in hepatitis C virus and HIV/hepatitis C virus co-infection: infiltrating cells, cytokines, and influence of HAART.
Publication
Long-distance interactive expert advice in highly treatment-experienced HIV-infected patients.
Publication
Long-distance interactive expert advice in highly treatment-experienced HIV-infected patients.
Publication
Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study.
Publication
Maraviroc for previously treated patients with R5 HIV-1 infection.
Publication
Modelled in vivo HIV fitness under drug selective pressure and estimated genetic barrier towards resistance are predictive for virological response.
Publication
Modelled in vivo HIV fitness under drug selective pressure and estimated genetic barrier towards resistance are predictive for virological response.
Publication
Nadir CD4 cell count predicts neurocognitive impairment in HIV-infected patients.
« first
‹ previous
…
64
65
66
67
68
69
70
71
72
…
next ›
last »
IrsiCaixa: We want to express our condolences for the loss of Charles Boucher, an excellent scientist who believed and supported the IrsiCaixa project since the very beginning. Our thoughts are with his family, friends and colleagues. https://t.co/pto8
IrsiCaixa: SECUENCIACIÓN #SARSCoV2 -- | #IrsiCaixaContesta ------ @marc_noguera contesta preguntas sobre la importancia de secuenciar las muestras de las personas infectadas por el #coronavirus. ---- Pero, ¿qué significa exactamente secuenciar? ¿
IrsiCaixa: SEQÜENCIACIÓ #SARSCoV2 -- | #IrsiCaixaContesta ------ @marc_noguera contesta preguntes sobre la importància de seqüenciar les mostres de les persones infectades pel #coronavirus. ---- Però, què vol dir exactament seqüenciar? I per q
IrsiCaixa: RT @ISGLOBALorg: Què sabem de la immunitat contra el #SARSCoV2 i quines són les implicacions per a la #salutpública? -- El #GCMSC, promogut…
IrsiCaixa: JobOffer | Last call, we are hiring ‼️ We are looking for a -------------- -------------- to work in liaison between the Managing Director and research groups ⏰ Application deadline: 28/02 -- https://t.co/Kx3eDvHtDa https://t.co/M7BNGlU
IrsiCaixa: RT @rac1: -- Les persones ja vacunades, poden transmetre el coronavirus? Si el virus arriba al seu cos, poden contagiar altres persones?…
IrsiCaixa: Les persones que pateixen #COVID19 persistent, sobretot dones d'entre 40 i 50 anys, poden patir fins a 15 símptomes al mateix temps. Els més comuns són: dolor toràcic, disfunció del nervi vague, febrícules i problemes digestius. http
IrsiCaixa: RT @rne: --Beatriz Mothe, viróloga @IrsiCaixa @hgermanstrias ha estado en @x3razonesRNE para aclararte si contagian o no los ya vacunados.…
IrsiCaixa: RT @CReSA_r: Join this seminar #research & #coronavirus -- "An overview of #SARSCoV2 and animal experiments at @CReSA_r --️ @MarcoBrustoli…
IrsiCaixa: RT @vallhebron: Un estudi liderat pel @VHIR_ ha mostrat que l'activació d'un tipus de cèl·lules del sistema immunitari facilitaria l'elimin…
Subscribe to our newsletter
I accept the sending of communications about IrsiCaixa activities, promotions and scientific and educational innovations
*
es
ca
en
Back to Top
